Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Application of Serum Anti-Müllerian Hormone (AMH) Measurements
Sponsor: Chinese University of Hong Kong
Summary
This study aims to assess the association of Anti-Müllerian hormone (AMH) with polycystic ovarian syndrome, premature ovarian insufficiency and fertility. The main objectives include the following: 1. To study the level of serum AMH in women with PCOS and to evaluate the utility of serum AMH in the diagnosis of PCOS. 2. To evaluate the level of serum AMH in women with POI and to evaluate the utility of serum AMH in the management of POI. 3. To evaluate the associations of basal AMH level with FSH level and AFC respectively for women undergoing ART treatment. 4. To determine the optimal regimen of gonadotropin for ovarian stimulation for women undergoing ART treatment. 5. To evaluate the predictive value of serum AMH in reproductive outcomes including oocyte quality, embryo quality, pregnancy loss, clinical pregnancy and live birth rate in women undergoing ART treatment.
Key Details
Gender
FEMALE
Age Range
10 Years - 44 Years
Study Type
OBSERVATIONAL
Enrollment
300
Start Date
2022-06-22
Completion Date
2026-12-31
Last Updated
2025-03-27
Healthy Volunteers
No
Conditions
Locations (1)
The Chinese University of Hong Kong
Hong Kong, Hong Kong